Janssen Biotech, Inc., a subsidiary of Johnson & Johnson, is a leading biopharmaceutical company headquartered in the United States. Founded in 2009, it has rapidly established itself in the biotechnology industry, focusing on innovative treatments in areas such as immunology, oncology, and infectious diseases. With a commitment to advancing healthcare, Janssen Biotech is renowned for its core products, including biologics and targeted therapies that address complex medical conditions. The company’s unique approach to drug development and its robust pipeline have positioned it as a key player in the global market. Notable achievements include the successful launch of groundbreaking therapies that have transformed patient care, solidifying Janssen Biotech's reputation for excellence and innovation in the biopharmaceutical landscape.
We don't have data for Janssen Biotech, Inc., but we can show you information about their parent organization instead.
View parent company